Protagenic Therapeutics, Inc.\new earnings releases PTIX

Annual Quarterly

Protagenic Therapeutics, Inc.\new last reported quarterly results on Apr 1, 2011, for the quarter ended Mar 31, 2011. It usually reports 1–48 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 1–48 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Apr 1, 2011
1 days after quarter end
—
ended Mar 31, 2011
—
—
—
Nov 15, 2010
46 days after quarter end
—
ended Sep 30, 2010
—
—
—
Aug 17, 2010
48 days after quarter end
—
ended Jun 30, 2010
—
—
—
May 11, 2010
41 days after quarter end
—
ended Mar 31, 2010
—
—
—
Nov 12, 2009
43 days after quarter end
—
ended Sep 30, 2009
—
—
—
Aug 14, 2009
45 days after quarter end
—
ended Jun 30, 2009
—
—
—
May 12, 2009
42 days after quarter end
—
ended Mar 31, 2009
—
—
—
Feb 17, 2009
48 days after quarter end
—
ended Dec 31, 2008
—
—
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTIX (OTC)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1022899
Former names
Atrinsic, Inc. (until Jun 20, 2016); NEW MOTION, INC. (until Jun 30, 2009); MPLC, Inc. (until Apr 2, 2007); MILLBROOK PRESS INC (until May 23, 2005)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.